Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer

Summary

Current therapies for Stage IV Kidney Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV Kidney Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV Kidney Cancer.

Timeline

Start

1996-03-27

Primary completion

2005-01-23

Completion

2005-01-23

Drugs

Indications